Hormone Therapy & Side Effects For High-Risk (Gleason 8) скачать в хорошем качестве

Hormone Therapy & Side Effects For High-Risk (Gleason 8)

Donate to PCRI: https://pcri.org/donate/ For more information, visit https://pcri.org 0:30 Why is Gleason 8 cancer considered "high-risk?" 2:57 Do men with localized Gleason 8 prostate cancer need hormone treatment? 4:38 Does the volume or location of the disease affect the treatment plan? 6:38 Are PSMA scans, usually covered by insurance for high-risk patients? 7:19 What is the difference between first and second generation hormone therapy? 8:59 What side effects are associated with hormone therapy? 11:13 Can weight gain be associated with gynecomastia and breast enlargement? 11:50 What effect does hormone therapy usually have on PSA levels? 13:39 How long does it take the effects of hormone therapy to subside? 14:15 Can younger Gleason 8 patients attempt short course hormone therapy? 15:27 How universal are the side effects of hormone therapy? 16:34 Alex's conclusions 17:47 If you need more help Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org To learn more about prostate cancer, visit http://www.pcri.org Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.